Many of the goals mentioned in the plan intersect with the mission of the NIH Office of Research on Women’s Health (ORWH).
The National Institutes of Health (NIH) recently released the NIH-Wide Strategic Plan for COVID-19 Research, which aims to accelerate development of therapeutic interventions, vaccines and diagnostics. The plan consists of five elements:
Many of the goals mentioned above intersect with those of the NIH Office of Research on Women’s Health (ORWH).
In fact, the strategic plan notes that it will address maternal health and pregnancy outcomes as they relate to COVID-19 in ongoing and future studies, with consideration of COVID-19 and “maternal morbidity, pregnancy-related alterations to the immune system, preterm birth, infant health, prenatal and postnatal care, rate of cesarean section delivery, possible mother-to-fetus transmission, possible mother-to-child transmission at birth, and possible transmission via breastfeeding.”1
More information on the NIH-Wide Strategic Plan for COVID-19 Research can be found here.